Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 15, 2025 | Albert George Beraldo Lead Independent Director | xxxxxxxxxxxxx | C$61376 |
| Jan 11, 2025 | David Hyman Chief Financial Officer | xxxxxxxxxxxxx | C$29000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Medicenna Therapeutics Corp (MDNAF)?
Currently, no data Available
What percentage of Medicenna Therapeutics Corp (MDNAF) stock is held by institutional investors?
Currently, no data Available
What percentage of Medicenna Therapeutics Corp (MDNAF) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Medicenna Therapeutics Corp (MDNAF)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.